










Atlas Genet Cytogenet Oncol Haematol. 1999; 3(2)  
 
93 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
OPEN ACCESS JOURNAL AT INIST-CNRS 
t(17;19)(q22;p13) 
Franck Viguié 
Laboratoire de Cytogénétique - Service d'Hématologie Biologique, Hôpital Hôtel-Dieu, 75181 Paris Cedex 
04, France (FV) 
 
Published in Atlas Database: May 1999 
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t1719ID1078.html 
DOI: 10.4267/2042/37516 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 1999 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Clinics and pathology 
Disease 
Acute lymphoblastic leukemia (ALL) 
Phenotype/cell stem origin 
Precursor-B cell immunophenotype; characteristic 
expression of surface markers CD10, CD19, TdT, 
HLA-DR. 
Epidemiology 
Less than 1% of ALL cases; 1% of childhood B-ALL ; 
sex ratio 1M/1F; more frequent in children. 
Clinics 
Frequent disseminated intravascular coagulation at 









Presents usually as a balanced translocation 
t(17;19)(q22;p13); in some cases, only the 
der(19)t(17;19) is observed, but not the der(17); the






Found in appproximately 50% of cases. 
Variants 
The translocation t(1;19)(q23;p13) and the 
t(17;19)(q22;p13) can be considered as variants of each 
other. 
Genes involved and proteins 





Basic leucine zipper (bZIP) transcription factor; 
normally expressed in hepatocytes and, at lower level, 
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E2A encodes the basic helix loop helix (bHLH) 
transcription factors E12 and E47; expressed in most 
cell types. 





Fusion gene E2A-HLF on der(19); two types of 
genomic rearrangements: type 1 results from a 
crossover between E2A intron 13 and HLF intron 3, 
type 2 from a crossover between E2A intron 12 and 
HLF intron 3 
- t(17;19) type I: 5' E2A exons 1 to 13 <-> cryptic exon 
formed by E2A intron/HLF intron sequences to 
reestablish a reading frame <-> HLF exon 4 in 3' 
- t(17;19) type II: 5' E2A exons 1 to 12 <-> HLF exon 4 
in 3'. 
Transcript 
Expression of two mRNAs of 4.4 and 4.8 kb with the 





The fusion results in linking the amino-terminal 
transactivation domains 1 and 2 of E2A to the carboxy-
terminal leucine zipper and basic domain of HLF; the
minor structural difference induced in both types of 







The fusion gene encodes a chimeric transcription factor 
E2A-HLF with altered DNA binding affinity compared 
with native HLF; it functions as an antiapoptotic 
transcription factor in leukemic cell transformation; 
when E2A-HLF protein was introduced into murine 
pro-B lymphocytes, it reverted both interleukin-3-
dependent and p53-mediated apoptosis; E2A-HLF 
could act by regulating expression of downstream 
target genes: possible activation of target genes 
normally repressed in B-cell precursors by another 
bZIP protein gene, E4BP4 (dominant negative effect by 
heterodimerization with endogenous proteins?). 
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